The chemokine Fractalkine in patients with severe traumatic brain injury and a mouse model of closed head injury

Journal of Cerebral Blood Flow and Metabolism

Volumn 24, Issue 10, 2004, Pages 1110-1118

  Rancan, Mario ^a   Bye, Nicole ^a   Otto, Vivianne I ^b   Trentz, Otmar ^c   Kossmann, Thomas ^a   Frentzel, Stefan ^d   Morganti Kossmann, Maria Cristina ^a  

^a ALFRED HOSPITAL   (Australia)

^b ETH ZURICH   (Switzerland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Blood brain barrier; Cell adhesion molecules; Chemokines; Neuroinflammation; Traumatic brain injury

Indexed keywords

CHEMOKINE; CX3C CHEMOKINE; FRACTALKINE;

ADOLESCENT; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN INJURY; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; ENCEPHALITIS; FEMALE; HEAD INJURY; HUMAN; LEUKOCYTE; MALE; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ANIMALS; BLOOD-BRAIN BARRIER; BRAIN INJURIES; CHEMOKINES, CX3C; DISEASE MODELS, ANIMAL; FEMALE; HEAD INJURIES, CLOSED; HUMANS; LEUKOCYTES; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MIDDLE AGED; RECEPTORS, CYTOKINE; RECEPTORS, HIV; RNA, MESSENGER; SOLUBILITY;

EID: 4944228603     PISSN: 0271678X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.WCB.0000133470.91843.72     Document Type: Article

References (37)

1. Anthony DC, Blond D, Dempster R, Peryy VH (2001) Chemokine targets in acute brain injury and disease. In: Progress in brain research (Castellano Lopez B, Nieto-Sampedro M, eds), Elsevier Science B. V., Amsterdam, pp 507-524
2. 3C chemokine fractalkine in pulmonary arterial hypertension. Am J Respir Crit Care Med 165:1419-1425
3. Bazan JF, Bacon KB, Hardiman G, Wang W, Soo K, Rossi D, Greaves DR, Zlotnik A, Schall TJ (1997) A new class of membrane-bound chemokine with a CX3C mofif. Nature 385:640-644
4. Beck GC, Yard BA, Breedijk AJ, Van Ackern K, Van Der Woude FJ (1999) Release of CXC-chemokines by human lung microvascular endothelial cells (LMVEC) compared with macrovascular umbilical vein endothelial cells. Clin Exp Immunol 118:298-303
5. Combadiere C, Potteaux S, Gao JL, Esposito B, Casanova S, Lee EJ, Debre P, Tedgui A, Murphy PM, Mallat Z (2003) Decreased atherosclerotic lesion formation in CX3CR1/apolipoprotein E double knockout mice. Circulation 107:1009-1016
6. Cook DN, Chen SC, Sullivan LM, Manfra DJ, Wiekowski MT, Prosser DM, Vassileva G, Lira SA (2001) Generation and analysis of mice lacking the chemokine fractalkine. Mol Cell Biol 21:3159-3165
7. Fischer FR, Santambrogio L, Luo Y, Berman MA, Hancock WW, Dorf ME (2000) Modulation of experimental autoimmune encephalomyelitis: effect of altered peptide ligand on chemokine and chemokine receptor expression. J Neuroimmunol 110:195-208.
8. Fraticelli P, Sironi M, Bianchi G, D'Ambrosio D, Albanesi C, Stoppacciaro A, Chieppa M, Allavena P, Ruco L, Girolomoni G, Sinigaglia F, Vecchi A, Mantovani A (2001) Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses. J Clin Invest 107:1173-1181
9. Hans VH, Kossmann T, Lenzlinger PM, Probstmeier R, Imhof HG, Trentz O, Morganti-Kossmann MC (1999) Experimental axonal injury triggers interleukin-6 mRNA, protein synthesis and release into cerebrospinal fluid. J Cereb Blood Flow Metab 19:184-194
10. Harrison JK, Jiang Y, Chen S, Xia Y, Maciejewski D, McNamara RK, Streit WJ, Salafranca MN, Adhikari S, Thompson DA, Botti P, Bacon KB, Feng L (1998) Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. Proc Natl Acad Sci U S A 95:10896-10901
11. Harrison JK, Jiang Y, Wees EA, Salafranca MN, Liang HX, Feng L, Belardinelli L (1999) Inflammatory agents regulate in vivo expression of fractalkine in endothelial cells of the rat heart. J Leukoc Biol 66:937-944
12. Hughes PM, Botham MS, Frentzel S, Mir A, Perry VH (2002) Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, during acute and chronic inflammation in the rodent CNS. Glia 37:314-327
13. Jennett B, Teasdale G, Braakman R, Minderhoud J, Knill-Jones R (1976) Predicting outcome in individual patients after severe head injury. Lancet 1:1031-1034
14. 3CR1 function by targeted deletion and green fluorescent proteirt reporter gene insertion. Mol Cell Biol 20:4106-4114
15. 3CL1) in inflammatory diseases of the nervous system. J Neuroimmunol 137:210-217
16. Kossmann T, Stahel PF, Lenzlinger PM, Redl H, Dubs RW, Trentz O, Schlag G, Morganti-Kossmann MC (1997) Interleukin-8 released into the cerebrospinal fluid after brain injury is associated with blood-brain barrier dysfunction and nerve growth factor production. J Cereb Blood Flow Metab 17:280-289
17. Marshall LF, Marshall SB, Klauber MR, Clarck MVB, Eisenberg HM, Jane JA, Luerssen TG, Marmarou A, Foulkes M (1991) A new classification of head injury based on computerized tomography. J Neurosurg 75:S14-S20
18. Meucci O, Fatatis A, Simen AA, Miller RJ (2000) Expression of CX3CR1 chemokine receptors on neurons and their role in neuronal survival. Proc Natl Acad Sci U S A 97:8075-8080
19. Morganti-Kossmann MC, Hans VH, Lenzlinger PM, Dubs R, Ludwig E, Trentz O, Kossmann T (1999) TGF-beta is elevated in the CSF of patients with severe traumatic brain injuries and parallels blood-brain barrier function. J Neurotrauma 16:617-628
20. Morganti-Kossmann MC, Rancan M, Otto VI, Stahel PF, Kossmann T (2001) Role of cerebral inflammation after traumatic brain injury: a revisited concept. Shock 16:165-177
21. Nishiyori A, Minami M, Ohtani Y, Takami S, Yamamoto J, Kawaguchi N, Kume T, Akaike A, Satoh M (1998) Localization of fractalkine and CX3CR1 mRNAs in rat brain: does fractalkine play a role in signaling from neuron to microglia? FEBS Lett 429:167-172
22. Otto VI, Heinzel-Pleines UE, Gloor SM, Trentz O, Kossmann T, Morganti-Kossmann MC (2000) sICAM-1 and TNF-alpha induce MIP-2 with distinct kinetics in astrocytes and brain microvascular endothelial cells. J Neurosci Res 60:733-742
23. Otto VI, Stahel PF, Rancan M, Kariya K, Shohami E, Yatsiv I, Eugster HP, Kossmann T, Trentz O, Morganti-Kossmann MC (2001) Regulation of chemokines and chemokine receptors after experimental closed head injury. Neuroreport 12:2059-2064
24. Pan Y, Lloyd C, Zhou H, Dolich S, Deeds J, Gonzalo JA, Vath J, Gosselin M, Ma J, Dussault B, Woolf E, Alperin G, Culpepper J, Gutierrez-Ramos JC, Gearing D (1997) Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation. Nature 387:611-617
25. Pleines UE, Stover JF, Kossmann T, Trentz O, Morganti-Kossmann MC (1998) Soluble ICAM-1 in CSF coincides with the extent of cerebral damage in patients with severe traumatic brain injury. J Neurotrauma 15:399-409
26. Rancan M, Otto V, Hans VH, Gerlach I, Jork R, Trentz O, Kossmann T, Morganti-Kossmann MC (2001) Upregulation of ICAM-1 and MCP-1 but not of MIP-2 and sensorimotor deficit in response to traumatic axonal injury in rats. J Neurosci Res 63:438-446
27. Rancan M, Morganti-Kossmann MC, Barnum SR, Saft S, Schmidt OI, Ertel W, Stahel PF (2003) CNS-targeted complement inhibition mediates neuroprotection after closed head injury in transgenic mice. J Cereb Blood Flow Metab 23:1070-1074
28. Reiber H, Felgenhauer K (1987) Protein transfer at the blood cerebrospinal fluid barrier and the quantitation of the humoral immune response within the central nervous system. Clin Chim Acta 163:319-328
29. Soriano SG, Amaravadi LS, Wang YF, Zhou H, Yu GX, Tonra JR, Fairchild-Huntress V, Fang Q, Dunmore JH, Huszar D, Pan Y (2002) Mice deficient in fractalkine are less susceptible to cerebral ischemia-reperfusion injury. J Neuroimmunol 125:59-65
30. Stahel PF, Kariya K, Shohami E, Barnum SR, Eugster H, Trentz O, Kossmann T, Morganti-Kossmann MC (2000a) Intracerebral complement C5a receptor (CD88) expression is regulated by TNF and lymphotoxin-alpha after closed head injury in mice. J Neuroimmunol 109:164-172
31. Stahel PF, Shohami E, Younis FM, Kariya K, Otto VI, Lenzlinger PM, Grosjean MB, Eugster HP, Trentz O, Kossmann T, Morganti-Kossmann MC (2000b) Experimental closed head injury: analysis of neurological outcome, blood-brain barrier dysfunction, intracranial neutrophil infiltration, and neuronal cell death in mice deficient in genes for pro-inflammatory cytokines. J Cereb Blood. Flow Metab 20:369-380
32. Stahel PF, Morganti-Kossmann MC, Perez D, Redaelli C, Gloor B, Trentz O, Kossmann T (2001) Intrathecal levels of complement-derived soluble membrane attack complex (sC5b-9) correlate with blood-brain barrier dysfunction in patients with traumatic brain injury. J Neurotrauma 18:773-781.
33. Stocker R, Bernays R, Kossmann T, Imhof HG (1995) Monitoring and treatment of acute head injury. In: The integrated approach to trauma care (Goris RJA, Trentz O, eds), Berlin: Springer Verlag, pp 196-210
34. Tarozzo G, Campanella M, Ghiani M, Bulfone A, Beltramo M (2002) Expression of fractalkine and its receptor, CX3CR1, in response to ischaemia-reperfusion brain injury in the rat. Eur J Neurosci 15:1663-1668
35. Tsou CL, Haskell CA, Charo IF (2001) Tumor necrosis factor-alpha- converting enzyme mediates the inducible cleavage of fractalkine. J Biol Chem 276:44622-44626
36. Zlotnik A, Yoshie O (2000) Chemokines: a new classification system and their role in immunity. Immunity 12:121-127
37. Zujovic V, Schussler N, Jourdain D, Duverger D, Taupin V (2001) In vivo neutralization of endogenous brain fractalkine increases hippocampal TNFalpha and 8-isoprostane production induced by intracerebroventricular injection of LPS. J Neuroimmunol 115:135-143